<PAGE> 1
May 22, 2000
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Mr. Andrew Thorp
Re: K-V Pharmaceutical Company Registration Statement on Form S-3
(File No. 333-33372)
Ladies and Gentlemen:
We hereby request withdrawal of the above-referenced Registration Statement. The
Company has determined not to proceed with the offering of shares of its common
stock contemplated by the Registration Statement because of current market
conditions. None of the securities which were subject to the Registration
Statement have been offered or sold.
Please direct any comments or questions concerning this requested withdrawal to
our counsel, Thomas A. Litz of Thompson Coburn LLP, phone number (314) 552-6072,
fax number (314) 552-7000.
Sincerely,
K-V PHARMACEUTICAL COMPANY
/s/ Gerald R. Mitchell
Gerald R. Mitchell
Vice President and Treasurer
cc: Allison R. Schneirov
